... visits, pain scores and health distress in arthritis patients with chronic pain. Results were comparable ... Plymouth, UK, the 'Challenging Pain' programme enrolled 186 patients into 18 workshop groups ...
... activation of the MMP-1 gene causing breakdown of collagen (the proteins that constitute cartilage). Arthritis patients start to experience pain when cartilage starts to erode.
Because AP-1 and SAF- ...
Rheumatoid arthritis patients who failed to respond to initial treatment with rituximab (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second ...
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first six years after starting anti-tumor necrosis factor therapy.
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis patients continue to suffer from pain. Researchers have found that inflammation is associated with heightened pain ...
... have brought dramatic gains in treatment for rheumatoid arthritis patients. Etanercept, the only FDA-approved biologic for ... rate of 0.12 SAEs per patient year. This rate did not increase with long- ...
... journal/arthritis), suggest an increased risk of melanoma, as well as other malignancies, for RA patients receiving ... average of 9.3 years per patient, 87 malignancies were identified.
Researchers then ...
The five-year waiting time that many Newfoundland and Labrador arthritis patients endure for treatment is unacceptable, a patient says.
... critical that dental professionals and medical professionals work together when treating a patient living with rheumatoid arthritis. This partnership will assure that both the oral and overall health ...
... therapy is effective and well-tolerated in ankylosing spondylitis, rheumatoid arthritis and psoriatic arthritis patients with a previously inadequate response to anti-tumour necrosis factor therapies ...
... Paris, France, show that over half of rheumatoid arthritis patients resistant to methotrexate monotherapy improved ... shown that 24 ABA and 23 IFX patients achieved LDAS (but not remission) at six months ...
... – infliximab, etanercept and adalimumab – which have had a dramatic effect on the symptoms of rheumatoid arthritis patients, protecting the joints from further deterioration in the vast majority of ...
(PhysOrg.com) -- People with arthritis are to take part in new research carried out at The University of Manchester to find out more about how the placebo effect works.
... drugs influence HBV infection in IBD patients. A research article to be published on 28 May 2008, ... 1 case of fulminant hepatitis in rheumatoid arthritis patient both with positive HBsAg and treated ...
... , but if people stop exercising, the benefits will go away."
The researchers found that patients with arthritis who learned exercise habits through physical activity interventions reported decreases ...
